Inventor
PAVLIV LEO
US40 patents
⚠️ This page may combine multiple inventors who share the name “PAVLIV LEO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUMBERLAND PHARMACEUTICALS INC
20 patentsUS8952065B2Feb 10, 2015
Acetylcysteine composition and uses thereof
CUMBERLAND PHARMACEUTICALS INC16 citations92
US8653061B2Feb 18, 2014
Acetylcysteine composition and uses thereof
CUMBERLAND PHARMACEUTICALS INC17 citations92
US6727286B2Apr 27, 2004
Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
CUMBERLAND PHARMACEUTICALS INC31 citations92
US9693998B2Jul 4, 2017
Compositions and methods of treating cardiac fibrosis with ifetroban
CUMBERLAND PHARMACEUTICALS INC4 citations82
US9327028B2May 3, 2016
Acetylcysteine compositions and methods of use thereof
CUMBERLAND PHARMACEUTICALS INC12 citations80
US11806400B2Nov 7, 2023
Injectable ibuprofen formulation
CUMBERLAND PHARMACEUTICALS INC2 citations71
US10314824B2Jun 11, 2019
Compositions and methods of treating cardiac fibrosis with ifetroban
CUMBERLAND PHARMACEUTICALS INC1 citations71
US10064845B2Sep 4, 2018
Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists
CUMBERLAND PHARMACEUTICALS INC2 citations68
US11571412B2Feb 7, 2023
Thromboxane receptor antagonists in AERD/asthma
CUMBERLAND PHARMACEUTICALS INC0 citations62
US12161632B2Dec 10, 2024
Compositions and methods of treating cardiac fibrosis with ifetroban
CUMBERLAND PHARMACEUTICALS INC0 citations61
US10925860B2Feb 23, 2021
Compositions and methods of treating cardiac fibrosis with ifetroban
CUMBERLAND PHARMACEUTICALS INC0 citations61
US9931311B2Apr 3, 2018
Treating critically ill patients with intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC1 citations60
US9649284B2May 16, 2017
Treating critically ill patients with intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC1 citations60
US9138404B2Sep 22, 2015
Treating critically ill patients with intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC1 citations60
US9114068B2Aug 25, 2015
Treating patients with intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC2 citations60
US8933115B2Jan 13, 2015
Stabilized statin formulations
CUMBERLAND PHARMACEUTICALS INC1 citations60
US10583126B2Mar 10, 2020
Compositions and methods of treating cardiac fibrosis with ifetroban
CUMBERLAND PHARMACEUTICALS INC0 citations51
US10016399B2Jul 10, 2018
Compositions and methods of treating cardiac fibrosis with ifetroban
CUMBERLAND PHARMACEUTICALS INC0 citations51
US9820966B2Nov 21, 2017
Stabilized statin formulations
CUMBERLAND PHARMACEUTICALS INC0 citations50
US10456380B2Oct 29, 2019
Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists
CUMBERLAND PHARMACEUTICALS INC0 citations48
PAVLIV LEO
10 patentsUS8399445B2Mar 19, 2013
Acetylcysteine composition and uses thereof
PAVLIV LEO17 citations92
US8148356B2Apr 3, 2012
Acetylcysteine composition and uses therefor
PAVLIV LEO22 citations92
US8722738B2May 13, 2014
Acetycysteine compositions and methods of use thereof
PAVLIV LEO18 citations89
US9072661B2Jul 7, 2015
Injectable ibuprofen formulation
PAVLIV LEO4 citations71
US9012508B2Apr 21, 2015
Administration of intravenous ibuprofen
PAVLIV LEO2 citations62
US9295639B2Mar 29, 2016
Treating critically ill patients with intravenous ibuprofen
PAVLIV LEO1 citations60
US9072710B2Jul 7, 2015
Injectable ibuprofen formulation
PAVLIV LEO3 citations60
US8871810B2Oct 28, 2014
Treating critically ill patients with intravenous ibuprofen
PAVLIV LEO1 citations60
US8778907B2Jul 15, 2014
Lactulose for bowel evacuation
PAVLIV LEO1 citations51
US8735452B2May 27, 2014
Treating patients with intravenous ibuprofen
PAVLIV LEO1 citations50